MAP0004

· Allergan

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MAP0004, covering 2013-10-22 to 2013-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of MAP0004 in Adult Migraineurs [Phase 3]